Novel biomarkers for early targeted and individualized treatment in Juvenile Idiopathic Arthritis

BACKGROUND: The programmed cell death protein-1 (PD-1) and its ligands (PD-L 1 and 2) suppress immune responses, thus promoting self-tolerance. Among the immunomodulatory cells, acting through the PD-1 pathway, are the B-regulatory cells (Bregs). The role of the PD-1 pathway in Juvenile Idiopathic A...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mediterr J Rheumatol
Egile Nagusiak: Koutsonikoli, Artemis, Taparkou, Anna, Pratsidou-Gkertsi, Polyxeni, Sgouropoulou, Vassiliki, Dimitroulas, Theodoros, Trachana, Maria
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Mediterranean Journal of Rheumatology (MJR) 2020
Gaiak:
Research Protocol
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7362122/
https://ncbi.nlm.nih.gov/pubmed/32676564
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31138/mjr.31.2.230
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak